The COVID-19 pandemic has driven unprecedented efforts to identify existing treatments that can be quickly and effectively repurposed to reduce morbidity and mortality. In this issue of Cell Metabolism, Zhang et al. (2020) report an association between statin use and improved outcomes in a large observational study of hospitalized COVID-19 patients. Given the widespread availability, low cost, and safety of statins, this promising result should be further investigated in randomized controlled trials.
All Keywords
【초록키워드】 Treatment, Randomized controlled trials, COVID-19 pandemic, outcome, morbidity and mortality, association, hospitalized COVID-19 patients, effort, widespread, identify, investigated, reduce, 【제목키워드】 drug, statin, Teaching, New,
【초록키워드】 Treatment, Randomized controlled trials, COVID-19 pandemic, outcome, morbidity and mortality, association, hospitalized COVID-19 patients, effort, widespread, identify, investigated, reduce, 【제목키워드】 drug, statin, Teaching, New,